Asset Details
Do you wish to reserve the book?
Essential updates 2019/2020: Perioperative and surgical management of gastric cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Essential updates 2019/2020: Perioperative and surgical management of gastric cancer
Do you wish to request the book?
Essential updates 2019/2020: Perioperative and surgical management of gastric cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Essential updates 2019/2020: Perioperative and surgical management of gastric cancer
2021
Overview
Perioperative and surgical management of gastric cancer have been changing as pivotal phase II trials and landmark phase III trials offer new insights to the existing knowledge. The results of many landmark trials have been published or presented in the past year, many of which have changed or will change current clinical practice. For example, FLOT4 has completely changed the regimen of perioperative chemotherapy in Europe. Furthermore, evidence for minimally invasive surgery for clinical Stage I was firmly established by KLASS‐01 and JCOG0912 for distal gastrectomy and CLASS‐02, KLASS‐03, and JCOG1401 for total gastrectomy. Moreover, promising results were provided by CLASS‐01 and KLASS‐02 for locally advanced gastric cancer. For adjuvant chemotherapy, JACCRO GC‐07 (START‐2) has provided a new doublet regimen for pathological Stage III, which is often refractory to chemotherapy. Conversely, JCOG0501 poses a significant challenge for advanced tumors, such as large type 3 and scirrhous (type 4) tumors. In this review, we briefly review recent updates and discuss future perspectives of gastric cancer treatment. The article reviewed updates in the management of gastric cancer surgery by covering most pivotal recent trials and studies, and then discusses future perspectives of gastric cancer treatment.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
